Rohini Gomathinayagam 1 , Ji Hee Ha 1 , Muralidharan Jayaraman 1 , Yong Sang Song 2 , Ciro Isidoro 3 , Danny N Dhanasekaran 1
Affiliations
1 Stephenson Cancer Center, Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
2 Department of Obstetrics and Gynecology, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
3 Laboratory of Molecular Pathology and NanoBioImaging, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
PMID: 33033708
PMCID: PMC7523033
DOI: 10.15430/JCP.2020.25.3.136
Review: J Cancer Prev. 2020 Sep 30;25(3):136-151. doi: 10.15430/JCP.2020.25.3.136.
Abstract
Thymoquinone (TQ) is a bioactive component derived from the seeds of Nigella sativa that are commonly as black cumin. Evidences indicate that the medicinal properties of TQ have been recognized for more than 2000 years. TQ has been shown to possess potent chemopreventive properties that include anti-inflammatory and anti-neoplastic activities. Recent studies have unraveled the multiple mechanisms through which TQ exerts its chemopreventive and anticancer activity in different cancer cells in a contextual manner. The present review aims to provide a brief compendium on the molecular mechanisms through which TQ inhibits signaling pathways underlying cancer genesis, progression, and metastasis.
Keywords: Antineoplastic agent; Chemoprevention; Neoplasms; Nigella sativa; Thymoquinone.
